首页> 外国专利> Combined product, method of producing the same, kit of parts, method of treating a condition, uses of a product or kit of melagatran or a pharmaceutically acceptable derivative thereof, together with dexamethasone or a pharmaceutically acceptable derivative thereof of the same

Combined product, method of producing the same, kit of parts, method of treating a condition, uses of a product or kit of melagatran or a pharmaceutically acceptable derivative thereof, together with dexamethasone or a pharmaceutically acceptable derivative thereof of the same

机译:组合产品,其制造方法,试剂盒,治疗病症的方法,美拉加群或其药学上可接受的衍生物与地塞米松或其药学上可接受的衍生物一起使用的产品或试剂盒的用途

摘要

"COMBINED PRODUCT, METHOD FOR PRODUCTION OF THE SAME, PART KIT, METHOD OF TREATMENT OF A CONDITION, USES OF A PRODUCT OR PART OF KIT AND MELAGATRAN OR A PHARMACEUTICALLY ACCEPTABLE DERIVATIVE BY THE SAME OR ALARMALLY ACCOMMODATED ACCEPTABLE OF THE SAME ". there is provided a combined product comprising: (A) melagatran or a pharmaceutically acceptable derivative thereof; and (B) dexamethasone or a pharmaceutically acceptable derivative thereof, wherein each of components (A) and (B) is formulated in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as the use of such a combined product in treatment of conditions including disseminated intravascular coagulation.
机译:“组合产品,相同零件的生产方法,成套工具,条件的处理方法,成套产品或零件的使用以及美拉格坦或相同或类似用途的药物可接受的衍生物”。提供了一种组合产品,其包含:(A)美拉加群或其药学上可接受的衍生物; (B)地塞米松或其药学上可接受的衍生物,其中将组分(A)和(B)中的每一种与药学上可接受的佐剂,稀释剂或载体混合配制,以及将此类组合产品用于治疗疾病包括弥散性血管内凝血。

著录项

  • 公开/公告号BR0213311A

    专利类型

  • 公开/公告日2004-10-13

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号BR20020213311

  • 发明设计人 MARGARETA ELG;

    申请日2002-10-24

  • 分类号A61K31/573;A61K38/05;A61P29/00;

  • 国家 BR

  • 入库时间 2022-08-21 23:12:00

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号